Found 1309 clinical trials
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
, bladder cancer, and specified GI malignancies (defined as CRC, gastric/GEJ cancer, HCC, PDAC, or SCAC)
- 46 views
- 11 Jul, 2022
- 19 locations
Colorectal Cancer
the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.
- 11 views
- 21 Apr, 2022
- 1 location
A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM-120 for the Treatment of Anxiety Symptoms
This is a Phase 2, multi-center, randomized, double-blind, parallel-group, dose-finding study to assess the effect of 4 doses of MM-120 (25, 50, 100 or 200 μg freebase-equivalent) for the treatment of anxiety symptoms in subjects diagnosed with generalized anxiety disorder (GAD).Link to the study website: https://www.anxietyresearchstudy.com/?utm_campaign=wcg&utm_source=cw&utm_medium=digital&mpt=wcgcw
- 0 views
- 01 Feb, 2023
- 19 locations
An investigational research study designed to confirm therapeutic equivalence of study inhaler to an inhaled product currently on the market for the treatment of asthma. 3-4 visits in this study. Compensation for participation for those who qualify.
This asthma research study involves 3-4 visits and should complete in about 6 weeks. Morning appointments required and can be done Monday-Saturday. Visits are two hours or less. Compensation for participation is provided to those who qualify.
- 116 views
- 23 Nov, 2020
- 1 location
A 5 day course of an investigational antiviral tablet for those positive to RSV.
5 visits over 2 weeks testing an investigational medication for RSV. Must be between 18-75 years and experiencing cold and flu like symptoms.
- 120 views
- 23 Nov, 2020
- 1 location
Metastatic Colorectal Cancer with wild-type KRAS tumors.
Metastatic Colorectal Cancer with wild-type KRAS tumors.
- 270 views
- 25 Mar, 2021
- 1 location
FINCH 1: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 weeks in Combination with Methotrexate to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
FINCH 1: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 weeks in Combination with Methotrexate to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
- 820 views
- 25 Mar, 2021
- 1 location
Prostate Cancer with/without bone metastasis
Prostate Cancer with/without bone metastasis
- 364 views
- 08 Nov, 2020
- 1 location
Advanced Colorectal or Lung Cancer Screening
Advanced Colorectal or Lung Cancer Screening
- 180 views
- 25 Mar, 2021
- 1 location